linsidomine has been researched along with pirsidomine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busse, R; Hecker, M; Mordvintcev, PI; Mülsch, A; Vanin, AF | 1 |
| Arkonac, BM; Kersten, JR; Nijhawan, N; Warltier, DC; Wynsen, JC | 1 |
2 other study(ies) available for linsidomine and pirsidomine
| Article | Year |
|---|---|
Enzymic and nonenzymic release of NO accounts for the vasodilator activity of the metabolites of CAS 936, a novel long-acting sydnonimine derivative.
Topics: Animals; Blood Vessels; Cattle; Cyclic GMP; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Female; In Vitro Techniques; Male; Molsidomine; Muscle, Smooth, Vascular; Nitric Oxide; Nitroso Compounds; Piperidines; Rabbits; Swine; Sydnones; Vasodilator Agents | 1993 |
Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside and nitroglycerin.
Topics: Animals; Blood Pressure; Dogs; Heart Rate; Hemodynamics; Injections, Intravenous; Molsidomine; Nitric Oxide; Nitroglycerin; Nitroprusside; Sydnones; Vasodilator Agents | 1996 |